| Literature DB >> 28904716 |
Bouchaib Hemmaoui1, Mohamed Sahli1, Noureddine Errami1, Ahmed Rouihi1, Mohamed Habib Bahalou1, Ilias Benchaifai1, Amine Ennouali1, Sara Britel1, Ismail Nakkabi1, Ali Jahidi1, Mohamed Zalagh1, Saloua Ouaraini1, Fouad Benariba1.
Abstract
Partial laryngectomy with either cricohyoidoepiglottopexy (CHEP) are mainly used to treat glottic cancers becuse they ensure a satisfactory preservation of physiological functions and satisfactory local carcinologic control. Our study aimed to analyze the functional and carcinologic results of this surgical technique. We conducted a retrospective study of patients undergoing partial laryngectomy with either cricohyoidoepiglottopexy in our Hospital between 2011 and 2014. We analyzed the epidemiological data, the surgical peculiarities, the functional outcomes and the carcinologic control of the disease. A total of 16 patients were included in this study. All our patients had T1 or T2 glottis squamous cell carcinoma. Functional outcomes were generally simple, especially in cases where the preservation of the 2 cricoarytenoid units was possible (75% of cases). However post-operative complications were reported in 31.25%. Carcinologic control was satisfactory, only one patient experienced local recurrence. Partial laryngectomy with either cricohyoidoepiglottopexy (CHEP) is a safe surgery preserving physiological functions and ensuring satisfactory quality of life. It also allows for good carcinologic control (it is subject of course to compliance with surgical indications).Entities:
Keywords: Partial surgery; carcinologic control; complications; crico-hyoido-epiglottopexy
Mesh:
Year: 2017 PMID: 28904716 PMCID: PMC5579443 DOI: 10.11604/pamj.2017.27.191.11955
Source DB: PubMed Journal: Pan Afr Med J
Figure 1Classification TNM de nos patients
Figure 2Complications postopératoires notées dans notre série
Résultats fonctionnels de la LPS-CHEP dans différentes séries
| Auteur/Année | Nombre de cas | Délai de la SNG | Délai de décanulation | Alimentation orale (%) |
|---|---|---|---|---|
| Naudo et al 1997 [ | 122 | 22j | 8j (3-90j) | - |
| De Vincentiis et al 1998 [ | 51 | 15j | 25j (15-90j) | - |
| Bron et al 2000 [ | 69 | 22j | 27j (8-85j) | - |
| Notre étude |
Résultats oncologiques de la LPS-CHEP dans différentes séries
| Leone et al [ | 152 cas | 92,1% | 83,5% |
| Park et al [ | 116 cas | 89,7% | 66,6% |
| Laccourreye et al [ | 62 cas | 98,2% | 86,5% |
| Notre série | 16 cas | 93,75% | - |